Sanofi says Beyfortus to be broadly available in more Canadian territories soon
Sanofi (SNY) announced Beyfortus will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon ...
2 clinics to offer new 'game changer' RSV shots for babies in Hamilton area, doctor says
This season will be the first time in Ontario that nirsevimab (sold under the brand name Beyfortus) is used to protect babies ...
Stockhouse14d
Beyfortus® immunization to protect infants from RSV has begun
Beyfortus® is the first immunization designed for all infants to help prevent RSV lower respiratory tract disease through their first RSV season. Beyfortus® is also indicated for ...
FiercePharma16d
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
In the meantime, Sanofi remains “very confident” in the Beyfortus readouts it’s published thus far, he said. Speaking to the data on protection afforded by Beyfortus through six months ...
Sanofi Launches Beyfortus Immunization Against RSV For Infants In Canada This Fall
Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest ...
FierceBiotech24d
With trial win, Merck's RSV antibody clesrovimab looks poised to take on Sanofi and AZ's Beyfortus
In the RSV market for infants, AstraZeneca and Sanofi’s Beyfortus leads the way. It achieved sales of 547 million euros ($592 million) in 2023. While cross-trial comparisons carry inherent ...
STAT24d
Potential competition for RSV prophylactic Beyfortus
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning! For those who ...